NCKU, 精神學科

NCKU, 精神學科
分類清單

成大醫院精神部2017年期刊論文發表

SCI:6篇; SSCI:0篇;本部同仁(第一/通訊作者:4篇; Impact Factor(>5:0篇; 3~5: 4篇)) 106.03.31

1. Hui-Hua Chang, Tzu-Yun Wang王姿云, I-Hui Lee李怡慧, Sheng-Yu Lee李聖玉, Kao-Chin Chen陳高欽,
San-Yuan Huang, Yen-Kuang Yang楊延光, Ru-Band Lu陸汝斌, Po-See Chen陳柏熹*: C-reactive protein: a differential biomarker for major depressive disorder and bipolar II disorder. World Journal of Biological Psychiatry 2017 Feb;18(1):63-70 (SCI) Impact Factor: 4.159

2. Wei-Hung Chang張維紘, Kao-Chin Chen陳高欽, I-Hui Lee李怡慧, Mei-Hung Chi紀美宏, Po-See Chen
陳柏熹, Wei Jen Yao姚維仁, Nan Tsing Chiu邱南津, Yen- Kuang Yang楊延光*: Unaltered dopamine
transporter availability in drug-naïve patients with schizophrenia after 6 months of antipsychotics
treatment: a naturalistic study. Journal of Clinical Psychopharmacology 2017 Feb;37(1):21-26 (SCI) Impact
Factor: 3.000

3. Sheng-Yu Lee李聖玉, Shiou-Lan Chen陳秀蘭, Tzu-Yun Wang王姿云, Yun-Hsuan Chang張芸瑄, Po-See
Chen陳柏熹, San-Yuan Huang, Nian-Sheng Tzeng, Liang-Jen Wang, I-Hui Lee李怡慧, Kao-Chin Chen陳高
欽, Yen-Kuang Yang楊延光, Ru-Band Lu陸汝斌*: The COMT Val158Met Polymorphism is Associated with
Response to Add-on Dextromethorphan Treatment in Bipolar Disorder. Journal of Clinical
Psychopharmacology 2017 Feb;37(1):94-98 (SCI) Impact Factor: 3.000

4. Chih-Hsing Wu, Chin-Sung Chang, Yen Kuang Yang楊延光, Lie-Hang Shen, Wei-Jen Yao*: Comparison of
brain serotonin transporter using [I-123]-ADAM between obese and non-obese young adults without an eating disorder. PLoS ONE 2017 Feb;12(2):e0170886 ~1- e0170886 ~10(SCI) Impact Factor: 3.057

5. Esther Ching-Lan Lin*, Michael Berk, Pei-Chen Hsu, Ru-Band Lu陸汝斌: A nurse-led psychoeducational
program“BalancingMySwing”improves medication adherence among Taiwanese Han-Chinese with
bipolar II disorder. Neuropsychiatry 2017 Mar;7(3):640-647 (SCI) Impact Factor:1.456

6. Po-See Chen陳柏熹*, HH Chang*, C-C Huang, CC Lee, S-Y Lee, S-L Chen, S-Y Huang, Yen- Kuang Yang楊延光, Ru-Band Luu陸汝斌: A longitudinal study of the association between the GNB3 C825T polymorphism and metabolic disturbance in bipolar II patients treated with valproate. Pharmacogenomics Journal 2017 Mar;17(2):155-161 (SCI) Impact Factor:3.784